1. A newly synthesized Ligustrazine stilbene derivative inhibits PDGF-BB induced vascular smooth muscle cell phenotypic switch and proliferation via delaying cell cycle progression
    Chunlian Peng et al, 2017, European Journal of Pharmacology CrossRef
  2. Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats
    Nicholas E. Buglak et al, 2018, Redox Biology CrossRef
  3. Association Between Statin Use at the Time of Intra-abdominal Surgery and Postoperative Adhesion-Related Complications and Small-Bowel Obstruction
    Frank I. Scott et al, 2021, JAMA Network Open CrossRef
  4. Screening and functional prediction of differentially expressed circRNAs in proliferative human aortic smooth muscle cells
    Wei Chen et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
  5. Baicalin prevents pulmonary arterial remodeling in vivo via the AKT/ERK/NF‐κB signaling pathways
    Guosen Yan et al, 2019, Pulmonary Circulation CrossRef
  6. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats
    Ning Zhu et al, 2016, International Journal of Cardiology CrossRef
  7. Ginsenoside Rh1 Inhibits Angiotensin II-Induced Vascular Smooth Muscle Cell Migration and Proliferation through Suppression of the ROS-Mediated ERK1/2/p90RSK/KLF4 Signaling Pathway
    Diem Thi Ngoc Huynh et al, 2022, Antioxidants CrossRef
  8. Inhibitory effects of hydroxysafflor yellow A on PDGF-BB-induced proliferation and migration of vascular smooth muscle cells via mediating Akt signaling
    YANMIN SONG et al, 2014, Molecular Medicine Reports CrossRef
  9. Inhibitory effect of Puerariae radix flavones on platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cells via PI3K and ERK pathways
    HUI LI et al, 2015, Experimental and Therapeutic Medicine CrossRef
  10. Rosuvastatin inhibits high glucose-stimulated upregulation of VCAM-1 via the MAPK-signalling pathway in endothelial cells
    Moo Hyun Kim et al, 2018, Acta Cardiologica CrossRef
  11. MicroRNA‐21 drives the switch to a synthetic phenotype in human saphenous vein smooth muscle cells
    Aliah R. Alshanwani et al, 2018, IUBMB Life CrossRef
  12. Atorvastatin-loaded spray-dried PLGA microparticles for local prevention of intimal hyperplasia: Drug release rate optimization and activity on synthetic vascular smooth muscle cells
    Tamara Melnik et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
  13. The role of microRNAs in the involvement of vascular smooth muscle cells in the development of atherosclerosis
    Linqing Li et al, 2019, Cell Biology International CrossRef
  14. Death-associated protein kinase 3 mediates vascular structural remodelling via stimulating smooth muscle cell proliferation and migration
    Tatsuya Usui et al, 2014, Clinical Science CrossRef
  15. microRNA‑612 is downregulated by platelet‑derived growth factor‑BB treatment and has inhibitory effects on vascular smooth muscle cell proliferation and migration via directly targeting AKT2
    Chen Chen et al, 2017, Experimental and Therapeutic Medicine CrossRef
  16. Dihydromyricetin prevents monocrotaline-induced pulmonary arterial hypertension in rats
    Qinghai Li et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  17. The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms
    Yasin Ahmadi et al, 2017, Chemico-Biological Interactions CrossRef
  18. Vasculo-protective effect of BMS-309403 is independent of its specific inhibition of fatty acid-binding protein 4
    Yuta Okamura et al, 2017, Pflügers Archiv - European Journal of Physiology CrossRef
  19. Notoginsenoside Rb1 inhibits activation of ERK and p38 MAPK pathways induced by hypoxia and hypercapnia
    XIAOXIAO QIU et al, 2016, Experimental and Therapeutic Medicine CrossRef
  20. Research progress on the pharmacy of tetramethylpyrazine and its pharmacological activity in cardiovascular and cerebrovascular diseases
    Yafang Zhang et al, 2022, Journal of Pharmacy and Pharmacology CrossRef
  21. Ligustrazine attenuates the platelet-derived growth factor-BB-induced proliferation and migration of vascular smooth muscle cells by interrupting extracellular signal-regulated kinase and P38 mitogen-activated protein kinase pathways
    LIFEI YU et al, 2015, Molecular Medicine Reports CrossRef
  22. Rho/ROCK Signal Cascade Mediates Asymmetric Dimethylarginine-Induced Vascular Smooth Muscle Cells Migration and Phenotype Change
    Yi-ming Zhou et al, 2014, BioMed Research International CrossRef
  23. SNX10 Plays a Critical Role in MMP9 Secretion via JNK‐p38‐ERK Signaling Pathway
    Chun Zhou et al, 2017, Journal of Cellular Biochemistry CrossRef
  24. Involvement of MicroRNA-133a in the Development of Arteriosclerosis Obliterans of the Lower Extremities via RhoA Targeting
    Yongxin Li et al, 2015, Journal of Atherosclerosis and Thrombosis CrossRef
  25. Astragaloside IV inhibits platelet-derived growth factor-BB-stimulated proliferation and migration of vascular smooth muscle cells via the inhibition of p38 MAPK signaling
    ZHUO CHEN et al, 2014, Experimental and Therapeutic Medicine CrossRef
  26. Downregulation of miR‑142‑5p inhibits human aortic smooth muscle cell proliferation and migration by targeting MKL2
    Wei Wu et al, 2020, Molecular Medicine Reports CrossRef